Anti-vegfa antibody or antigen-binding fragment thereof and use thereof
AssigneeQuaerite Biopharm Research (Beijing) Co., Ltd.
InventorsJinliang HUANG, Huiqin LIU
Life of this patent
Estimating the term…
Abstract
Provided herein are an anti-VEGFA antibody or an antigen-binding fragment thereof and use thereof. The anti-VEGFA antibody or the antigen-binding fragment thereof features high thermal stability, high water solubility, small molecular weight, simple expression and purification processes, and high affinity for VEGFA, and is capable of effectively blocking the VEGFA signaling pathway and effectively blocking VEGFA-induced pathological processes such as vascular endothelial cell proliferation and angiogenesis, thus having potential applications in the treatment of VEGFA-associated diseases.
Claims16
1-24. (canceled)
An anti-VEGFA antibody or an antigen-binding fragment thereof, comprising CDR-H1, CDR-H2, and CDR-H3 of a heavy chain variable region, wherein
- an amino acid sequence of the CDR-H1 comprises SYTMG (SEQ ID NO:
- 1) or an amino acid sequence having at least 80% identity to SYTMG (SEQ ID NO:
- 1);
- an amino acid sequence of the CDR-H2 comprises AISKGGYKYX1X2VSLEA (SEQ ID NO:
- 2) or an amino acid sequence having at least 80% identity to AISKGGYKYX1X2VSLEA (SEQ ID NO:
- 2);
- an amino acid sequence of the CDR-H3 comprises TRAYGSSRLX3LAX4TYEY (SEQ ID NO:
- 3) or an amino acid sequence having at least 80% identity to TRAYGSSRLX3LAX4TYEY (SEQ ID NO:
- 3).
Dependencies are inferred from the claim text.